Haleon Selects Salesforce Agentforce Life Sciences Cloud for Customer Engagement to Improve Engagement with Pharmacies and Healthcare Professionals with AI

Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world's #1 AI CRM, today announced that Haleon will leverage Salesforce to drive more effective engagement with pharmacies and healthcare professionals worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251008924109/en/

A pharmacist advises a consumer on the purchase of Haleon's Otrivin nasal mist.

A pharmacist advises a consumer on the purchase of Haleon's Otrivin nasal mist.

Haleon has chosen Salesforce Life Sciences Cloud for Customer Engagement , Data Cloud , and Agentforce to support its 4,500-strong sales force globally. The AI-powered solution will enable the global consumer healthcare company to have more productive customer interactions, deepening its relationships with pharmacists and healthcare professionals around the world. This should serve to benefit millions of consumers globally by giving more people better access to everyday healthcare products.

With Salesforce, Haleon's sales representatives will spend less time on administrative tasks and have access to data-driven insights on consumer demographics, shopping trends, and point-of-sale marketing. This will enable Haleon's sales representatives to focus their efforts on value-add activities such as bespoke activation plans for their customers.

Additionally, Haleon, maker of category leading brands like Sensodyne, Voltaren, and Centrum, will serve as a design partner for Salesforce Life Sciences Cloud for Customer Engagement. In this role, Haleon will influence the development of Salesforce's life sciences solutions to further address the specific needs of the consumer health industry, including by supporting product availability, shelf-life management, promotions, and inventory management across global retail and online channels.

"We are excited to partner with Salesforce to bring more effective, data-driven insights to our customers. This selection of Life Sciences Cloud and Agentforce will enable pharmacists and healthcare professionals to more efficiently deliver better everyday health to millions of people all around the world," commented Claire Dickson, Chief Digital and Technology Officer at Haleon.

Dickson continued, "We are also delighted to advise Salesforce on the development of the consumer health capabilities of the platform. We are committed to shaping the future of our industry and look forward to impacting the development of tools that will help support the growth of all our categories."

"Haleon's adoption of our next-generation Life Sciences Cloud for Customer Engagement and Agentforce will reimagine how the consumer health industry engages with pharmacies and HCPs through real-time insights and trusted AI," said Frank Defesche, General Manager of Life Sciences at Salesforce. "Their insights ensure we're meeting the complex, specific needs of the consumer healthcare industry without having to customize solutions - all while promoting greater productivity, innovation, and wellness."

Notes to Editors:

Learn more:

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com

About Salesforce

Salesforce helps organizations of any size reimagine their business for the world of AI. With Salesforce's trusted platform and Agentforce, organizations can bring humans together with agents to drive customer success—powered by AI, data, and action. With its long-standing history powering the healthcare industry, Salesforce continues to be invested in driving healthier outcomes for pharma and medtech organizations. Visit www.salesforce.com for more information.

Order Management is expected to be available as a part of Life Sciences Cloud for Customer Engagement starting October 2026. Any unreleased services or features referenced here are not currently available and may not be delivered on time or at all. Customers should make their purchase decisions based upon features that are currently available.

Haleon PR Contact:
Gemma Thomas
gemma.x.thomas@haleon.com

Salesforce PR Contact:
Maha Neouchy
pr@salesforce.com

News Provided by Business Wire via QuoteMedia

CRM
The Conversation (0)
Tartisan Nickel Corp. Intersects 11.0 Metres of 1.05% Ni, 0.33% Cu Including 2.0 Metres of 4.79% Ni, 1.25% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario

Tartisan Nickel Corp. Intersects 11.0 Metres of 1.05% Ni, 0.33% Cu Including 2.0 Metres of 4.79% Ni, 1.25% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario

Tartisan Nickel Corp. (CSE: TN,OTC:TTSRF) (OTCQB: TTSRF) (FSE: 8TA) ("Tartisan", or the "Company") is pleased to provide an update on the Company's flagship Kenbridge Nickel-Coppet-Cobalt Project, Sioux Narrows, Ontario. The drill program is designed to test the on strike and down dip potential... Keep Reading...
Mayfair Gold Presents the Initial Results from the 2025 Grade Control Drilling Program at the Fenn-Gib Project

Mayfair Gold Presents the Initial Results from the 2025 Grade Control Drilling Program at the Fenn-Gib Project

Mayfair Gold Corp. ("Mayfair", "Mayfair Gold", or the "Company") (TSXV: MFG,OTC:MFGCF) (NSYE: MINE) is pleased to announce the initial results from the tight-spaced, grade control drilling program ("Grade Control Program" or "Program") at the Fenn-Gib Project in Northern Ontario. Nick Campbell,... Keep Reading...
Lahontan Drills More Shallow Oxide Gold at West Santa Fe: 41m Grading 1.94 g/t Au Eq Including 9.1m Grading 4.14 g/t Au Eq

Lahontan Drills More Shallow Oxide Gold at West Santa Fe: 41m Grading 1.94 g/t Au Eq Including 9.1m Grading 4.14 g/t Au Eq

TORONTO, ON / ACCESS Newswire / February 10, 2026 / Lahontan Gold Corp. (TSXV:LG,OTC:LGCXF)(OTCQB:LGCXF)(FSE:Y2F) (the "Company" or "Lahontan") is pleased to announce more analytical results from our 2025 maiden drilling program at the Company's satellite West Santa Fe project, located only 13... Keep Reading...
Lahontan Drills Thick, Shallow Oxide Gold at West Santa Fe: 55m Grading 1.00 g/t AuEq Including 17m Grading 1.75 g/t AuEq

Lahontan Drills Thick, Shallow Oxide Gold at West Santa Fe: 55m Grading 1.00 g/t AuEq Including 17m Grading 1.75 g/t AuEq

TORONTO, ON / ACCESS Newswire / February 5, 2026 / Lahontan Gold Corp. (TSXV:LG,OTC:LGCXF)(OTCQB:LGCXF)(FSE:Y2F) (the "Company" or "Lahontan") is pleased to announce the first assay results from our 2025 Maiden drilling program at the Company's satellite West Santa Fe Project, located only 13 km... Keep Reading...
Nuvau Provides Corporate Update and Strategy for 2026

Nuvau Provides Corporate Update and Strategy for 2026

Building on exploration success at flagship Matagami project Nuvau Minerals Inc. (TSXV: NMC,OTC:NMCPF) is pleased to provide a corporate update, highlighting the success of 2025 exploration programs and plans for 2026. Previous exploration has resulted in significant gold and base metal... Keep Reading...

Interactive Chart

Latest Press Releases

Related News